Helicobacter pylori: A role in schizophrenia?

Medical Science Monitor

Volumn 14, Issue 7, 2008, Pages

  Yilmaz, Yusuf ^a   Gul, Cuma Bulent ^a   Arabul, Mahmut ^a   Eren, Mehmet Ali ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Helicobacter pylori; Hypothesis; Schizophrenia

Indexed keywords

DOPAMINE; HOMOCYSTEINE; POLYUNSATURATED FATTY ACID;

ARTICLE; BACTERIAL INFECTION; CHILDHOOD; CHRONIC INFLAMMATION; DISEASE COURSE; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HELICOBACTER PYLORI; HUMAN; HYPOTHESIS; MEDICAL RESEARCH; PATHOGENESIS; SCHIZOPHRENIA; SOCIAL STATUS;

DOPAMINE; FATTY ACIDS, UNSATURATED; HELICOBACTER PYLORI; HOMOCYSTEINE; HUMANS; INFLAMMATION; SCHIZOPHRENIA; SOCIOECONOMIC FACTORS;

EID: 48349137925     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bob P, Susta M, Chladek J et al: Neural complexity, dissociation and schizophrenia. Med Sci Mot, 2007; 13(10): HY1-5
2. Cooper B: Nature, nurture and mental disorder: old concepts in the new millennium. Br J Psychiatry Suppl, 2001; 40: s91-101
3. Meyer U, Yee BK, Feldon J: The neurodevelopmental impart of prenatal infections at different times of pregnancy the earlier the worse? Neuroscientist, 2007; 13: 241-56
4. Meyer U, Schwendener S, Feldon J, Yee BK: Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res, 2006; 173: 243-57
5. Torrey EF, Bartko JJ, Lun ZR, Yolken RH: Antibodies to Toxoplasma gondii in patients with echizophrenia: a meta-analysis. Schizophr Bull, 2007; 33: 729-56
6. Fellerhoff B, Laumbacher B, Mueller N et al: Associations between Chlamydophila infections, schizophrenia and risk of HLA-A10. Mol Psychiatry, 2007; 12: 264-72
7. Fellerhoff B, Laumbacher B, Wank R: High risk of schizophrenia and other mental disorders associated with chlamydial infections: hypothesis to combine drug treatment and adoptive immunotherapy. Med Hypotheses, 2005; 65: 243-52
8. Tret'iakov AIu, Karpov AG, Polushin PI, Zakharchenko SP: [Ulcer disease in schizophrenia: variants of combination and particular features of the course]. Eksp Klin Gastroenterol. 2005; 6: 88-93
9. Toda M, Abi-Dargham A: Dopamine hypothesis of schizophrenia: making sense of it all. Curr Psychiatry Rep, 2007; 9: 329-36
10. Weller G, Oxlade N, Dobbs SM et al: Role of inflammation in gastrointestinal tract in aetiology and pathogenesis of idiopathic parkinsonism. FEMS Immunol Med Microbiol, 2005; 44: 129-35
11. Schulz JD, Hawkes EL, Shaw CA: Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator. Med Hypotheses, 2006; 66: 1222-26
12. Martinez MG: Famotidine in the management of schizophrenia. Ann Pharmacother, 1999; 33: 742-47
13. Murakami K, Okimoto T, Kodama M et al: Comparison of amoxicillin- metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin- proton pump inhibitor treatment failures for Helicobacter pylori infection. Helicobacter, 2006; 11: 436-40
14. Du Bois TM, Deng C, Huang XF: Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 2005; 29: 878-88
15. Ohara K: The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 469-74E
16. Emsley R, Oosthuizen P, van Rensburg SJ: Clinical potential of omega-3 fatty acids in the treatment of schizophrenia. CNS Drugs, 2003; 17: 1081-91
17. Penner R, Fedorak RN, Madsen KL: Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases. Curr Opin Pharmacol, 2005; 5: 596-603
18. James MJ, Gibson PA, Cleland LG: Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr, 2000; 71: 343S-8S
19. Kaiya H, Uematsu M, Ofuji M et al: Elevated plasma prostaglandin E2 levels in schizophrenia. J Neural Transm, 1989; 77: 39-46
20. Robinson K, Argent RH, Atherton JC: The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol, 2007; 21: 237-59
21. Fan X, Goff DG, Henderson DC: Inflammation and schizophrenia. Expert Rev Neurother, 2007; 7: 789-96
22. Potvin S, Stip E, Sepehry AA et al: Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry, 2007; doi: 10.1016/j.biopsych.2007.09.024.
23. Manolakis A, Kapsoritakis AN, Potamianos SP: A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease. Helicobacter, 2007; 12: 287-97
24. Fan X, Pristach C, Liu EY et al: Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. Psychiatry Res, 2007; 149: 267-71
25. Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M: Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry, 2006; 11: 143-49
26. Brown AS, Susser ES: Homocysteine and schizophrenia: from prenatal to adult life. Prog Neuropsychopharmacol Biol Psychiatry, 2005; 29: 1175-80
27. Kempennan RF, Veurink M, van der Wal T et al: Low essential fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementation. Prostaglandins Leukot Essent Fatty Acids, 2006; 74: 75-85
28. Dierkes J, Ebert M, Malfertheiner P, Luley C: Helicobacter pylori infection, vitamin B12 and homocysteine. A review. Dig Dis, 2003; 21: 237-44
29. Parrott B, Lewine R: Socioeconomic status of origin and the clinical expression of schizophrenia. Schizophr Res, 2005; 75: 417-24
30. Malaty HM, Graham DY: Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut, 1994; 35: 742-45
31. Cenerelli S, Bonazzi P, Galeazzi R et al: Helicobacter pylori masks differences in homocysteine plasma levels between controls and type 2 diabetic patients. Eur J Clin Invest, 2002; 32: 158-62
32. Cardno AG, Gottesman II: Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet, 2000; 97: 12-17
33. Sawa A, Snyder SH: Schizophrenia: diverse approaches to a complex disease. Science. 2002; 296: 692-95
34. Ozdemir V, Jamal MM, Osapay K et al: Cosegregation of gastrointestinal ulcers and schizophrenia in a large national inpatient discharge database: revisiting the "brain-gut axis" hypothesis in ulcer pathogenesis. J Investig Med, 2007; 55: 315-20
35. De Hert M, Hautekeete M, De Wilde D, Peuskens J: High prevalence of Helicobacter pylori in institutionalized schizophrenic patients. Schizophr Res, 1997; 26: 243-44
36. Neff NE, Kuo G. Acute manic psychosis induced by triple therapy for H. pylori. J Am Board Fam Pract, 2002; 15: 66-68